KMPH Chart
- 52-Week Range: $4.02 - $15.47
- Market Capitalization: $163.86M
- Short Percentage: 0%
- Target Price: $19.50
- Shares Outstanding: 34.42M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
KMPH released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- KemPharm, Inc. (KMPH) CEO Travis Mickle on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 12th
- KemPharm Reports First Quarter 2022 Financial Results and Corporate UpdatesGlobeNewsWire | May 12th
- KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 30th
- KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate UpdatesGlobeNewsWire | March 30th
- KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical TrialGlobeNewsWire | March 21st
- KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep DisorderBenzinga | January 20th
- KemPharm to Host Investor Conference Call Detailing Plans for Pipeline ExpansionGlobeNewsWire | January 12th
Company Info
Website: https://kempharm.com
Address: 1180 Celebration Boulevard, Celebration, FL, United States, 34747
Sector: Healthcare
Industry: Biotechnology
Full time employees: 24
Address: 1180 Celebration Boulevard, Celebration, FL, United States, 34747
Sector: Healthcare
Industry: Biotechnology
Full time employees: 24
$KMPH when's the offering?
$KMPH lock and load
$KMPH Mindset is key
$KMPH what happened
$KMPH money comes and goes but your story stays with you the rest of your life. Apes for life ??
$KMPH still bullish
$KMPH Awaiting buy signal..
$KMPH day trade is ok to buy here but sell later
$KMPH go green today and we gap up tomrrow
$KMPH just added more